Lymphotoxicity and myelotoxicity of doxorubicin and SDZ PSC 833 combined chemotherapies for normal mice

A. Pourtier-Manzanedo, A. Didier, S. Froidevaux, F. Loor

Open source

DOI
10.1016/0300-483x(95)03056-l
Published
1995-05
Container
Toxicology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/0300-483x-95-03056-l,
  title = {Lymphotoxicity and myelotoxicity of doxorubicin and SDZ PSC 833 combined chemotherapies for normal mice},
  author = {A. Pourtier-Manzanedo and A. Didier and S. Froidevaux and F. Loor},
  year = {1995},
  journal = {Toxicology},
  doi = {10.1016/0300-483x(95)03056-l},
  url = {https://doi.org/10.1016/0300-483x(95)03056-l}
}

RIS

TY  - JOUR
TI  - Lymphotoxicity and myelotoxicity of doxorubicin and SDZ PSC 833 combined chemotherapies for normal mice
AU  - A. Pourtier-Manzanedo
AU  - A. Didier
AU  - S. Froidevaux
AU  - F. Loor
PY  - 1995
JO  - Toxicology
DO  - 10.1016/0300-483x(95)03056-l
UR  - https://doi.org/10.1016/0300-483x(95)03056-l
ER  - 

APA

Pourtier-Manzanedo, A., Didier, A., Froidevaux, S., & Loor, F. (1995). Lymphotoxicity and myelotoxicity of doxorubicin and SDZ PSC 833 combined chemotherapies for normal mice. Toxicology. https://doi.org/10.1016/0300-483x(95)03056-l

Source records